Laurus Labs Limited (NSE:LAURUSLABS)
1,088.10
-10.25 (-0.93%)
Apr 13, 2026, 3:29 PM IST
Laurus Labs Revenue
Laurus Labs had revenue of 17.78B INR in the quarter ending December 31, 2025, with 25.67% growth. This brings the company's revenue in the last twelve months to 67.22B, up 27.46% year-over-year. In the fiscal year ending March 31, 2025, Laurus Labs had annual revenue of 55.54B with 10.18% growth.
Revenue (ttm)
67.22B
Revenue Growth
+27.46%
P/S Ratio
8.82
Revenue / Employee
10.90M
Employees
6,167
Market Cap
592.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 55.54B | 5.13B | 10.18% |
| Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
| Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
| Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
| Mar 31, 2021 | 48.14B | 19.82B | 69.99% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Mankind Pharma | 139.14B |
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 88.50B |
Laurus Labs News
- 6 days ago - Laurus Labs receives creditor approval for composite scheme of arrangement - Business Upturn
- 20 days ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 24 days ago - Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42% - Business Upturn
- 25 days ago - Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 13: Laurus Labs down 2.56%, Ajanta Pharma falls 1.88%, Granules India drops 2.14% - Business Upturn
- 5 weeks ago - Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10% - Business Upturn
- 2 months ago - Laurus Labs Ltd (BOM:540222) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 2 months ago - Q3 2026 Laurus Labs Ltd Earnings Call Transcript - GuruFocus